Security key
92764N102
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 87,600,991
- Total 13F value
- $656,230,226
- Share change
- -387,878
- Put/Call ratio
- 941%
- SEC-reported price per share
- $7.49
- Number of holders
- 195
- Value change
- -$4,592,687
- Number of buys
- 96
- Number of sells
- 104
- Shares outstanding
- 168,677,036
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
195
Top holders
10
VIR full security history
Ownership snapshot
Full 13F holder table
Vir Biotechnology, Inc. SEC filings
Vir Biotechnology, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of VIR - Vir Biotechnology, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
SB INVESTMENT ADVISERS (U...
Disclosed value leader
SB INVESTMENT ADVISERS (U...
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
Lead comparable stake: 9.9%
Showing 1-6 of 15 holder rows.
Quick read
SB INVESTMENT ADVISERS (UK) LTD leads the comparable SEC ownership view at 9.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens SB INVESTMENT ADVISERS (UK) LTD's linked filing trail.
Comparable ownership
Top 5
SB INVESTMENT ADVISERS (UK) LTD
9.9%
BlackRock Finance, Inc.
9.7%
VANGUARD GROUP INC
7.6%
STATE STREET CORP
3%
BAILLIE GIFFORD & CO
2.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD |
13F
Company
|
9.9%
|
$148,487,965
16,684,041 shares
|
— | 30 Jun 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
9.7%
|
$146,263,685
16,434,122 shares
|
— | 30 Jun 2024 |
| VANGUARD GROUP INC |
13F
Company
|
7.6%
|
$114,358,032
12,849,217 shares
|
— | 30 Jun 2024 |
| STATE STREET CORP |
13F
Company
|
3%
|
$45,344,503
5,094,888 shares
|
— | 30 Jun 2024 |
| BAILLIE GIFFORD & CO |
13F
Company
|
2.3%
|
$34,899,054
3,921,242 shares
|
— | 30 Jun 2024 |
| ORBIMED ADVISORS LLC |
13F
Company
|
1.4%
|
$20,648,908
2,320,102 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
195
Shares
87,600,991
Rows available
195
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
213
Q3 2024 holders
195
Holder diff
-18
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|